Parametrica Management Ltd - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 111 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parametrica Management Ltd ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$433,000
+104.2%
9,754
-40.4%
0.47%
+113.1%
Q1 2017$212,000
+61.8%
16,367
+51.3%
0.22%
-38.8%
Q3 2016$131,000
-55.1%
10,817
-63.4%
0.36%
-83.7%
Q2 2014$292,000
+117.9%
29,578
+143.9%
2.21%
+32.2%
Q3 2013$134,00012,1251.67%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders